Bio-Techne

Social media sentiment, last 30 days

Average tone of posts mentioning TECH, from −1 (all negative) to +1 (all positive). Latest day: −0.30 across 58 mentions.

• Press releaseOct 8, 8:00 AM ETPRNewswire

  Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

• Press releaseSep 23, 9:20 AM ETPRNewswire

  Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

• Press releaseSep 22, 9:00 AM ETPRNewswire

  Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

• Press releaseSep 10, 3:12 PM ETPRNewswire

  $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN

• Press releaseSep 9, 3:24 PM ETPRNewswire

  Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders?

• Press releaseSep 8, 9:33 AM ETPRNewswire

  INVESTOR ALERT: The M&A Class Action Firm Launches Investigation of the Merger - AUUD, TECH, CZR and CBAN

• Press releaseSep 1, 6:30 AM ETPRNewswire

  Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals

• Press releaseAug 22, 4:43 AM ETBusiness Wire

  TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders

• Press releaseAug 17, 10:18 PM ETPRNewswire

  Are PAYO, TECH, CBAN Obtaining Fair Deals for their Shareholders?

• Press releaseAug 13, 6:30 AM ETPRNewswire

  Bio-Techne Corrects Dividend Announcement

• NewsAug 12, 6:41 AM ET

  Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate

• Press releaseAug 12, 6:30 AM ETPRNewswire

  Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

• Press releaseAug 12, 6:30 AM ETPRNewswire

  Bio-Techne Declares Dividend

• NewsJul 10, 9:26 AM ETVandana Singh

  Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover

• Press releaseJul 8, 6:30 AM ETPRNewswire

  Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

• Press releaseJul 2, 3:27 PM ETPRNewswire

  Are SYNA, IRDM, TECH, PATK Obtaining Fair Deals for their Shareholders?

• Press releaseJun 29, 4:21 PM ETBusiness Wire

  Bio-Techne Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bio-Techne Corporation - TECH

• Press releaseJun 29, 1:59 PM ETPRNewswire

  Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders?

• NewsJun 25, 2:14 PM ETPiero Cingari

  Micron Rallies 15%, Apple Sinks 6% On Memory Costs: Stock Market Today

• Press releaseJun 25, 1:53 PM ETPRNewswire

  Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

• NewsJun 25, 1:05 PM ET

  12 Health Care Stocks Moving In Thursday's Intraday Session

• Press releaseJun 25, 10:00 AM ETPRNewswire

  Shareholder Alert: Ademi LLP investigates whether Bio-Techne Corporation is obtaining a Fair Price for Public Shareholders

• NewsJun 25, 9:55 AM ETAvi Kapoor

  Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday

• NewsJun 25, 9:34 AM ETVandana Singh

  Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal

• Press releaseJun 25, 7:48 AM ETBusiness Wire

  TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders

• NewsJun 25, 6:21 AM ET

  CORRECTION: Germany's Merck KGaA To Acquire Bio-Techne At $73 Per Share In Cash At EV $11.3B; Deal Expected To Be Immediately Sales Accretive And EBITDA Pre Margin Post-Closing And EPS Pre Accretive By Year 3 Post-Closing

• Press releaseJun 25, 6:10 AM ETPRNewswire

  Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

• NewsJun 15, 8:47 AM ET

  'Activist Investor Ananym Urges Bio-Techne to Consider Selling' - Bloomberg News

• NewsJun 4, 6:41 AM ET

  Bio‑Techne And Refeyn Launch An Integrated Workflow To Characterize Charge And Size Variants In Bispecific Antibodies And Biosimilars

• Press releaseJun 4, 6:30 AM ETPRNewswire

  Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

• NewsMay 6, 5:03 PM ET

  Earnings Scheduled For May 6, 2026

• NewsMay 6, 1:35 PM ETPiero Cingari

  S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today

• NewsMay 6, 10:07 AM ET

  Bio-Techne Q3 2026 Earnings Call: Complete Transcript

• Press releaseMay 6, 6:30 AM ETPRNewswire

  Bio-Techne Releases Third Quarter Fiscal 2026 Results

• Press releaseMay 6, 6:30 AM ETPRNewswire

  Bio-Techne Declares Dividend

• Press releaseMay 4, 7:00 AM ETPRNewswire

  Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference

• Press releaseApr 16, 8:00 AM ETPRNewswire

  Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

• Press releaseFeb 4, 6:30 AM ETPRNewswire

  Bio-Techne Declares Dividend

• Press releaseFeb 4, 6:30 AM ETPRNewswire

  Bio-Techne Releases Second Quarter Fiscal 2026 Results

• NewsFeb 2, 6:35 AM ET

  Bio-Techne Launches New Synthetic Gel to Improve Stem Cell and Organoid Research

• Press releaseFeb 2, 6:30 AM ETPRNewswire

  Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

• Press releaseNov 5, 6:30 AM ETPRNewswire

  Bio-Techne Releases First Quarter Fiscal 2026 Results

• Press releaseNov 5, 6:30 AM ETPRNewswire

  BIO-TECHNE DECLARES DIVIDEND

• NewsNov 4, 12:02 PM ET

  An Overview of Bio-Techne's Earnings

• Press releaseNov 3, 7:00 AM ETPRNewswire

  ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics